Background: Salmonella enterica serovar Enteritidis is a cause of both poultry- and egg-associated enterocolitis globally and bloodstream-invasive nontyphoidal Salmonella (iNTS) disease in sub-Saharan Africa (sSA). Distinct, multi-drug resistant genotypes associated with iNTS disease in sSA have recently been described, often requiring treatment with fluoroquinolone antibiotics. In industrialised countries, antimicrobial use in poultry production has led to frequent fluoroquinolone resistance amongst globally prevalent enterocolitis-associated lineages.

Methodology/principal Findings: Twenty seven S. Enteritidis isolates from patients with iNTS disease and two poultry isolates, collected between 2007 and 2015 in the Ashanti region of Ghana, were whole-genome sequenced. These isolates, notable for a high rate of diminished ciprofloxacin susceptibility (DCS), were placed in the phyletic context of 1,067 sequences from the Public Health England (PHE) S. Enteritidis genome database to understand whether DCS was associated with African or globally-circulating clades of S. Enteritidis. Analysis showed four of the major S. Enteritidis clades were represented, two global and two African. All thirteen DCS isolates, containing a single gyrA mutation at codon 87, belonged to a global PT4-like clade responsible for epidemics of poultry-associated enterocolitis. Apart from two DCS isolates, which clustered with PHE isolates associated with travel to Spain and Brazil, the remaining DCS isolates, including one poultry isolate, belonged to two monophyletic clusters in which gyrA 87 mutations appear to have developed within the region.

Conclusions/significance: Extensive phylogenetic diversity is evident amongst iNTS disease-associated S. Enteritidis in Ghana. Antimicrobial resistance profiles differed by clade, highlighting the challenges of devising empirical sepsis guidelines. The detection of fluoroquinolone resistance in phyletically-related poultry and human isolates is of major concern and surveillance and control measures within the region's burgeoning poultry industry are required to protect a human population at high risk of iNTS disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605661PMC
http://dx.doi.org/10.1371/journal.pntd.0007485DOI Listing

Publication Analysis

Top Keywords

ints disease
16
dcs isolates
12
nontyphoidal salmonella
8
fluoroquinolone resistance
8
isolates
8
enteritidis
7
disease
5
ints
5
poultry
5
dcs
5

Similar Publications

Background: Enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi A in addition to gastroenteritis and invasive disease, predominantly attributable to nontyphoidal Salmonella serovars Typhimurium and Enteritidis, are major causes of death and disability across the globe. A broad-spectrum vaccine that protects against disease caused by typhoidal and nontyphoidal serovars of Salmonella is not available for humans but would prevent a considerable burden of disease worldwide.

Methods: We previously developed a broad-spectrum vaccine for Gram-negative bacteria that is based on the inner core domain of detoxified Escherichia coli O111, Rc (J5) mutant lipooligosaccharide, a highly conserved antigen across Gram-negative bacteria, complexed with an outer membrane protein of group B Neisseria meningitidis.

View Article and Find Full Text PDF

Objectives: Non-typhoidal (NTS) commonly causes a self-limiting illness but invasive disease (iNTS) can be life-threatening. Antimicrobial resistance (AMR) increases the risk of mortality. This systematic review aimed to estimate the proportion of NTS isolated in those attending healthcare services, serovar burden, AMR, serovar-specific AMR, and case fatality rate (CFR) in India, Bangladesh, Sri Lanka and Vietnam.

View Article and Find Full Text PDF
Article Synopsis
  • Invasive non-typhoidal Salmonella (iNTS), primarily caused by Enteritidis and Typhimurium, poses a major global health risk due to its association with severe diseases and gastroenteritis.
  • The study analyzed genomic and transcriptomic differences between blood samples (iNTS) and stool samples (non-iNTS) of these serovars, revealing few distinct genes and a similar phylogenetic relationship.
  • Findings indicated that Typhimurium blood isolates showed higher antimicrobial resistance and genomic degradation, but overall, few reliable biomarkers could differentiate iNTS from non-iNTS at both the genomic and transcriptomic levels, despite subtle genomic differences contributing to invasiveness.
View Article and Find Full Text PDF
Article Synopsis
  • Lorlatinib is a third-generation drug that effectively targets ALK and ROS1 tyrosine kinases in patients with advanced ALK-positive non-small cell lung cancer (NSCLC), showing promising long-term survival rates.
  • The study involved 367 adults with varying treatment backgrounds who took lorlatinib daily and assessed response rates, overall survival (OS), and safety.
  • Results indicated that patients had substantial improvements in OS across different treatment groups, with noted adverse events leading to dose adjustments in some cases, but the drug's safety profile remained generally stable over five years of follow-up.
View Article and Find Full Text PDF
Article Synopsis
  • Salmonella enterica serovar Panama is a significant cause of invasive non-typhoidal salmonellosis in Australia, despite being understudied, with a high incidence rate linked to international travel.
  • A study analyzed genomic epidemiology and antimicrobial resistance in S. Panama isolates in Victoria from 2000 to 2021, finding that over half exhibited multi-drug resistance, and colistin resistance was identified in one isolate.
  • The research also explored the growth dynamics of S. Panama in macrophages, revealing its ability to replicate more effectively compared to S. enterica serovar Typhimurium, although no specific genotype was linked to this enhanced replication.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!